Fig. 4
From: Recent knowledge of NFATc4 in oncogenesis and cancer prognosis
Survival analysis of NFATc4 in various cancers. A–C The data is from GEO database and analyzed by KM plotter (https://kmplot.com/analysis/index.php?p=background). A The GSE31210, a lung cancer dataset, shows that the high expression of NFATc4 is significantly related to favorable prognosis. B The GSE12276, a breast cancer dataset, shows that the high expression of NFATc4 is significantly related to poor prognosis. C The GSE26193, a ovarian cancer dataset, shows that the high expression of NFATc4 is significantly related to poor prognosis. D–F The data is from TCGA database and analyzed by GEPIA (http://gepia.cancer-pku.cn/index.html). D The CESC, a cervical cancer dataset, shows that the high expression of NFATc4 is significantly related to poor prognosis. E The SKCM, a skin cancer dataset, shows that the high expression of NFATc4 is significantly related to poor prognosis. F The COAD, a colon cancer dataset, shows that the high expression of NFATc4 is significantly related to poor prognosis